Acute pain management
Amyotrophic Lateral Sclerosis (ALS)
Inflammatory bowel disease
Post-Traumatic Stress Disorder
Spinal cord damage
As initially implemented, the law permits qualified patients to possess a 30-day supply of cannabis-infused, non-smokable products. but only non-smokable preparations allowed. Regulations announced by the Department of Health in 2017 states, registered organizations will be allowed to manufacture and distribute additional products including topicals such as lotions, ointments and patches, as well as solid and semi-solid products including chewable and effervescent tablets and lozenges. Certain non-smokable forms of ground plant material will also be permissible for manufacture and distribution."
Yes, as initially enacted, five producers of cannabis-based preparations and up to 20 dispensing centers were to be licensed by the state. In 2017, the Department of Health registered five additional entities to manufacture and dispense cannabis-infused products.
Yes, each certified patient may have up to two caregivers, and each caregiver may serve no more than five certified patients.